Changing incidence and subtypes of ALS in Modena, Italy: A 10-years prospective study

Amyotrophic Lateral Sclerosis

Volumn 12, Issue 6, 2011, Pages 451-457

  Georgoulopoulou, Eleni ^a   Vinceti, Marco ^a   Bonvicini, Francesca ^a   Sola, Patrizia ^a   Goldoni, Carlo Alberto ^b   Girolamo, Gianfranco De ^b   Ferraro, Diana ^a   Nichelli, Paolo ^a   Mandrioli, Jessica ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b Local Health Unit   (Italy)

Author keywords

ALS; Epidemiology; population based study

Indexed keywords

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CLINICAL FEATURE; DISEASE REGISTRY; FEMALE; HUMAN; INCIDENCE; ITALY; LIFE EXPECTANCY; LIFESPAN; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEX RATIO; STANDARDIZED INCIDENCE RATIO; SURVIVAL; TREND STUDY;

AGED; AGED, 80 AND OVER; AMYOTROPHIC LATERAL SCLEROSIS; FEMALE; HUMANS; ITALY; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; REGISTRIES;

EID: 80055029215     PISSN: 17482968     EISSN: 1471180X     Source Type: Journal    
DOI: 10.3109/17482968.2011.593037     Document Type: Article

References (29)

1. Logroscino G, Traynor BJ, Hardiman O, Chi ò A, Mitchell D, Swingler RJ, et al. Incidence of amyotrophic lateral sclerosis in Europe. J Neurol Neurosurg Psychiatry. 2010;81:385-90.
2. Durrleman S, Alperovitch A. Increasing trend of ALS in France and elsewhere: are the changes realNeurology. 1989;39:768-73. (Pubitemid 19150148)
3. Lilienfeld DE, Chan E, Ehland J, Godbold J, Landrigan PJ, Marsch G, et al. Rising mortality from motor neuron disease in the USA, 1962-1984. Lancet. 1989;1:710-3. (Pubitemid 19089229)
4. Kahana E, Zilber N. Changes in the incidence of amyotrophic lateral sclerosis in Israel. Arch Neurol. 1984;41:157-60. (Pubitemid 14177793)
5. Govoni V, Granieri E, Capone J, Manconi M, Casetta I. Incidence of amyotrophic lateral sclerosis in the Local Health District of Ferrara, Italy, 1964-1998. Neuroepidemiology. 2003;22:229-34. (Pubitemid 36693865)
6. Sorenson EJ, Stalker AP, Kurland LT, Windebank AJ. Amyotrophic lateral sclerosis in Olmsted County, Minnesota, 1925-1998. Neurology. 2002;59:280-2. (Pubitemid 34779192)
7. O' T oole O, Traynor BJ, Brennan P, Sheehan C, Frost E, Corr B. Epidemiology and clinical features of amyotrophic lateral sclerosis in Ireland between 1995 and 2004. J Neurol Neurosurg Psychiatry. 2007;79:30-2.
8. Forbes RB, Colville S, Parratt J, Swingler RJ. The incidence of motor neuron disease in Scotland. J Neurol. 2007;254:866-9. (Pubitemid 47222306)
9. Chiò A, Mora G, Calvo A, Mazzini L, Bottacchi E, Mutani R. Epidemiology of ALS in Italy. A 10-years prospective population based study. Neurology. 2009;72:725-31.
10. Logroscino G, Traynor BJ, Hardiman O, Chio A, Couratier P, Mitchell JD, et al. Descriptive epidemiology of amyotrophic lateral sclerosis: new evidence and unsolved issues. J Neurol Neurosurg Psychiatry. 2008;79:6-11.
11. Fang F, Valdimarsdottir U, Bellocco R, Ronnevi LO, Sparen P, Fall K, et al. Amyotrophic lateral sclerosis in Sweden, 1991-2005. Arch Neurol. 2009;66:515-9.
12. Murphy M, Quinn S, Young J, Parkin P, Taylor B. Increasing incidence of ALS in Canterbury, New Zealand: a 22-year study. Neurology. 2008;71:1889-95.
13. Brooks BR, Miller RG, Swash M, Munsat TL. World Federation of Neurology Research Group on Motor Neuron Diseases. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;1:293-9.
14. Wijesekera LC, Mathers S, Talman P, Galtrey C, Parkinson MH, Ganesalingam J, et al. Natural history and clinical features of the fl ail arm and fl ail leg ALS variants. Neurology. 2009;72:1087-94.
15. Gordon PH, Cheng B, Katz IB, Mitsumoto H, Rowland LP. Clinical features that distinguish PLS, upper motor neurondominant ALS, and typical ALS. Neurology. 2009;72: 1948-52.
16. Shoesmith CL, Findlater K, Rowe A, Strong MJ. Prognosis of amyotrophic lateral sclerosis with respiratory onset. J Neurol Neurosurg Psychiatry. 2007;78:629-31. (Pubitemid 46853901)
17. Mandrioli J, Faglioni P, Merelli E, Sola P. The epidemiology of ALS in Modena, Italy. Neurology. 2003;60:683-9.
18. Beghi E, Millul A, Micheli A, Vitelli E, Logroscino G. Incidence of ALS in Lombardy, Italy. Neurology. 2007;68:141-5.
19. The Scottish Motor Neuron Disease Research Group. The Scottish Motor Neuron Disease Register: a prospective study of adult onset motor neuron disease in Scotland. Methodology, demography and clinical features of incident cases in 1989. J Neurol Neurosurg Psychiatry. 1992;55:536-41.
20. Traynor BJ, Codd MB, Corr B, Forde C, Frost E, Hardiman O. Incidence and prevalence of ALS in Ireland, 1995-1997: a population based study. Neurology. 1999;52:504-9. (Pubitemid 29075594)
21. Logroscino G, Beghi E, Zoccolella S, Palagano R, Fraddosio A, Simone IL, et al. Incidence of amyotrophic lateral sclerosis in southern Italy: a population based study. J Neurol Neurosurg Psychiatry. 2005;76:1094-8. (Pubitemid 41081283)
22. Piemonte and Valle d'A osta Register for Amyotrophic Lateral Sclerosis (PARALS). Incidence of ALS in Italy. Evidence for a uniform frequency in Western countries. Neurology. 2001;56:239-44.
23. Seljeseth YM, Vollset SE, Tysnes OB. Increasing mortality from amyotrophic lateral sclerosis in NorwayNeurology. 2000;55:1-6.
24. Day TG, Scott M, Perring R, Doyle P. Motor neuron disease mortality in Great Britain continues to rise: examination of mortality rates 1975-2004. Amyotroph Lateral Scler. 2007; 8:337-42. (Pubitemid 350176931)
25. Turner MR, Kiernan MC, Leigh PN, Talbot K. Biomarkers in amyotrophic lateral sclerosis. Lancet Neurol. 2009;8: 94-109.
26. Noonan CW, White MC, Thurman D, Wong LY. Temporal and geographic variation in the United States motor neuron disease mortality, 1969-1998. Neurology. 2005;64:1215-21.
27. Sejvar JJ, Holman RC, Bresee JS, Kochanek KD, Schonberger LB. Amyotrophic lateral sclerosis mortality in the United States, 1979-2001. Neuroepidemiology. 2005;25:144-52. (Pubitemid 41207067)
28. Qureshi M, Schoenfeld DA, Paliwal Y, Shui A, Cudkowicz ME. The natural history of ALS is changing: improved survival. Amyotroph Lateral Scler. 2009;10:324-31.
29. Beghi E, Chiò A, Couratier P, Esteban J, Hardiman O, Logroscino G, et al. The epidemiology and treatment of ALS: focus on the heterogeneity of the disease and critical appraisal of therapeutic trials. Amyotroph Lateral Scler. 2011;12:1-10.